Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 3/20 | 0.45 |
| ▸ | LDHA | P00338 | 1/20 | 0.37 |
| ▸ | S1PR1 | P21453 | 3/20 | 0.37 |
| ▸ | S1PR3 | Q99500 | 1/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.36 |
| ▸ | AR | P10275 | 2/20 | 0.36 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.36 |
| ▸ | BACE1 | P56817 | 2/20 | 0.36 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.36 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | PLK1 | P53350 | 1/20 | 0.35 |
| ▸ | PTPN5 | P54829 | 1/20 | 0.34 |
| ▸ | ACHE | P22303 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6067691 | 0.96 | KIF11 (0.39) | KIF11LDHAS1PR1S1PR3CYP11B2 | |
| SCHEMBL29914918 | 0.89 | SCN9A (0.40) | KIF11LDHACYP11B2ARPDK2 | |
| SCHEMBL29914889 | 0.83 | KIF11 (0.47) | KIF11LDHAS1PR1S1PR3CYP11B2 | |
| SCHEMBL29266608 | 0.76 | ACHE (0.40) | KIF11S1PR1S1PR3BACE1HSD11B1 | |
| SCHEMBL2202989 | 0.76 | ACHE (0.40) | KIF11S1PR1S1PR3BACE1HSD11B1 | |
| SCHEMBL28223418 | 0.76 | HSD11B1 (0.49) | KIF11ARPDK2HSD11B1 | |
| SCHEMBL27638533 | 0.75 | S1PR1 (0.52) | KIF11S1PR1S1PR3ARPDK2 | |
| SCHEMBL5523215 | 0.74 | KIF11 (0.54) | KIF11ARBACE1HSD11B1 | |
| SCHEMBL29980535 | 0.74 | KIF11 (0.54) | KIF11ARBACE1HSD11B1 | |
| SCHEMBL11286015 | 0.74 | KIF11 (0.54) | KIF11ARBACE1HSD11B1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11444250-B2 | Composition of matter for use in organic light-emitting diodes | KYULUX, INC. (JP) | 2022-09-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11444250-B2 | Composition of matter for use in organic light-emitting diodes | CRY2, ALDH1A2, CYBA | KIF11 3284/4885LDHA 344/4885S1PR1 4317/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.